Correlation Between Allarity Therapeutics and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and Unicycive Therapeutics, you can compare the effects of market volatilities on Allarity Therapeutics and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Unicycive Therapeutics.
Diversification Opportunities for Allarity Therapeutics and Unicycive Therapeutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Allarity and Unicycive is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and Unicycive Therapeutics
Given the investment horizon of 90 days Allarity Therapeutics is expected to under-perform the Unicycive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Allarity Therapeutics is 1.16 times less risky than Unicycive Therapeutics. The stock trades about -0.26 of its potential returns per unit of risk. The Unicycive Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 71.00 in Unicycive Therapeutics on August 26, 2024 and sell it today you would lose (18.00) from holding Unicycive Therapeutics or give up 25.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allarity Therapeutics vs. Unicycive Therapeutics
Performance |
| Timeline |
| Allarity Therapeutics |
| Unicycive Therapeutics |
Allarity Therapeutics and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allarity Therapeutics and Unicycive Therapeutics
The main advantage of trading using opposite Allarity Therapeutics and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
| Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. HCW Biologics | Unicycive Therapeutics vs. Scpharmaceuticals | Unicycive Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |